shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

Updated on: 02 December,2021 11:37 AM IST  |  New Delhi
ANI |

According to the officials, the demand has been made due to the emergence of a new coronavirus variant 'Omicron'. The Serum Institute of India is the first Indian company to seek approval for the Covid-19 booster dose

SII seeks approval for Covishield vaccine as booster dose amid Omicron variant concerns

This picture has been used for representational purposes

The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country, officials informed ANI on Thursday.


According to the officials, the demand has been made due to the emergence of a new coronavirus variant 'Omicron'. The Serum Institute of India is the first Indian company to seek approval for the Covid-19 booster dose.


The Union government has also informed the Parliament that the National Technical Advisory Group on Immunization and National Expert Group on Vaccine Administration for Covid-19 are considering scientific evidence on the booster dose.


States like Rajasthan, Chhattisgarh, Karnataka and Kerala have also urged the Central government for booster dose amid another variant of concern, Omicron.

Recently, in an interview with a media organisation, Adar Poonawalla, the Chief Executive Officer of SII said that the scientists at Oxford may come out with a new vaccine that would act as a booster in six months' time against this new variant.

The new Omicron variant was first reported to the World Health Organization (WHO) by South Africa on November 24. According to the WHO, its high number of mutations in spike protein could make it more transmissible than all previous strains. South African medical officials have reported the variant was found in fully vaccinated individuals and the cases are mild. 

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK